Yabao Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 0.8% in First Half of 2022

Yabao Pharmaceutical Group Co.,Ltd. (亚宝药业集团股份有限公司) (600351.SH) reported a net profit of 98.3 million yuan in the first half of 2022, up 0.8% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, down 11.7% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 25.5%.